Reviewed by Michael Gill, B. Sc.
5 Paroxysmal Supraventricular Tachycardia Clinical Trials Near Me
Top Hospitals for Paroxysmal Supraventricular Tachycardia Clinical Trials
Image of Site # 0160 in Arkansas.
Site # 0160
Little Rock
1Active Trials
1All Time Trials for Paroxysmal Supraventricular Tachycardia
2021First Paroxysmal Supraventricular Tachycardia Trial
Image of Site # 0102 in Georgia.
Site # 0102
Atlanta
1Active Trials
1All Time Trials for Paroxysmal Supraventricular Tachycardia
2021First Paroxysmal Supraventricular Tachycardia Trial
Top Cities for Paroxysmal Supraventricular Tachycardia Clinical Trials
Image of Austin in Texas.
Austin
4Active Trials
Site # 1047Top Active Site
Image of Rapid City in South Dakota.
Rapid City
3Active Trials
Site # 0122Top Active Site
Paroxysmal Supraventricular Tachycardia Clinical Trials by Phase of Trial
Phase 3 Paroxysmal Supraventricular Tachycardia Clinical Trials
2Active Paroxysmal Supraventricular Tachycardia Clinical Trials
2Number of Unique Treatments
96Number of Active Locations
Paroxysmal Supraventricular Tachycardia Clinical Trials by Age Group
18+ Paroxysmal Supraventricular Tachycardia Clinical Trials
5Active Paroxysmal Supraventricular Tachycardia Clinical Trials
Most Recent Paroxysmal Supraventricular Tachycardia Clinical Trials
Top Treatments for Paroxysmal Supraventricular Tachycardia Clinical Trials
Treatment Name
Active Paroxysmal Supraventricular Tachycardia Clinical Trials
All Time Trials for Paroxysmal Supraventricular Tachycardia
First Recorded Paroxysmal Supraventricular Tachycardia Trial
Etripamil NS 70 mg
1
3
2018
Fluoroscopy reduction
1
1
2020
mCRM Therapy System
1
1
2021
Etripamil NS
1
1
2019
CyberHeart System
1
1
2015

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: November 16th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Loo BW Jr, Soltys SG, Wang L, Lo A, Fahimian BP, Iagaru A, Norton L, Shan X, Gardner E, Fogarty T, Maguire P, Al-Ahmad A, Zei P. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2015 Jun;8(3):748-50. doi: 10.1161/CIRCEP.115.002765. https://pubmed.ncbi.nlm.nih.gov/260825322 Loo BW Jr, Soltys SG, Wang L, Lo A, Fahimian BP, Iagaru A, Norton L, Shan X, Gardner E, Fogarty T, Maguire P, Al-Ahmad A, Zei P. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2015 Jun;8(3):748-50. doi: 10.1161/CIRCEP.115.002765. https://pubmed.ncbi.nlm.nih.gov/26082532